MBX 1416 (INN imapextide)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)NCT07029412MBX BiosciencesPhase 2Completed2026-04-18Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.